Physician profile
Benjamin C Ling
NPI 1710932579
$4,363.13
in general payments reported to CMS, 2019-2025
8 companies · $1,537 in 2025
The $1,537 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $437 · 2020: $172 · 2021: $1,427 · 2022: $225 · 2023: $374 · 2024: $192 · 2025: $1,537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,453 · Food and Beverage: $649.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,453.31 |
| Food and Beverage | $648.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $1,601.99 | 2023-2025 | Excelsius Gps, Mars 3v/3vl |
| Karl Storz Endoscopy-America | $1,235.07 | 2019-2021 | |
| Depuy Synthes Sales INC. | $774.51 | 2019-2025 | Expedium, Symphony, Trufill |
| Medtronic USA, INC. | $443.42 | 2019-2020 | |
| Medtronic, INC. | $214.30 | 2021-2025 | Anteralign Spinal System With Titan Nanolock Surface Technology, Aquamantys(Tm) |
| Sawtooth Surgical Solutions INC | $39.00 | 2025 | |
| Arteriocyte Medical Systems, INC. | $35.86 | 2023 | Magellan |
| Integra Lifesciences Corporation | $18.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Ling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.